Browse > Article
http://dx.doi.org/10.4142/jvs.2018.19.6.840

Ultrasonographic evaluation of skin thickness in small breed dogs with hyperadrenocorticism  

Heo, Seonghun (Institute of Animal Medicine, College of Veterinary Medicine, Gyeongsang National University)
Hwang, Taesung (Institute of Animal Medicine, College of Veterinary Medicine, Gyeongsang National University)
Lee, Hee Chun (Institute of Animal Medicine, College of Veterinary Medicine, Gyeongsang National University)
Publication Information
Journal of Veterinary Science / v.19, no.6, 2018 , pp. 840-845 More about this Journal
Abstract
The purpose of this study was to propose a standard for differentiation between normal dogs and patients with hyperadrenocorticism (HAC) by measuring skin thickness via ultrasonography in small breed dogs. Significant changes in skin thickness of patients treated with prednisolone (PDS) or patients with HAC treated with trilostane were evaluated. Skin thickness was retrospectively measured on three abdominal digital images obtained from small breed dogs weighing < 15 kg that underwent abdominal ultrasonography. Mean skin thickness of normal dogs was $1.03{\pm}0.25mm$ (mean ${\pm}$ SD). Both the HAC and PDS groups showed significantly thinner skin than that in the normal group. Seven of the 10 HAC patients treated with trilostane had increased skin thickness. The area under the curve value of 0.807 was based on the receiver operating characteristics (ROC) curve for differentiating normal dogs from HAC patients. Sensitivity was 76% and specificity was 73% when skin thickness was less than the 0.83 mm cutoff value. In conclusion, measurement of skin thickness in small breed dogs by using ultrasonography is likely to provide clinical information useful in differentiating HAC patients from normal dogs. However, exposure to PDS, trilostane, and other conditions may have a significant effect on skin thickness.
Keywords
dogs; hyperadrenocorticism; skin; thickness; ultrasonography;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Salmhofer W, Rieger E, Soyer HP, Smolle J, Kerl H. Influence of skin tension and formalin fixation on sonographic measurement of tumor thickness. J Am Acad Dermatol 1996, 34, 34-39.   DOI
2 Savvas M, Treasure J, Studd J, Fogelman I, Moniz C, Brincat M. The effect of anorexia nervosa on skin thickness, skin collagen and bone density. Br J Obstet Gynaecol 1989, 96, 1392-1394.   DOI
3 Schacke H, Docke WD, Asadullah K. Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther 2002, 96, 23-43.   DOI
4 Schoepe S, Schacke H, May E, Asadullah K. Glucocorticoid therapy-induced skin atrophy. Exp Dermatol 2006, 15, 406-420.   DOI
5 Alexander H, Miller DL. Determining skin thickness with pulsed ultra sound. J Invest Dermatol 1979, 72, 17-19.   DOI
6 Barthez PY, Nyland TG, Feldman EC. Ultrasonographic evaluation of the adrenal glands in dogs. J Am Vet Med Assoc 1995, 207, 1180-1183.
7 Behrend EN, Kooistra HS, Nelson R, Reusch CE, Scott-Moncrieff JC. Diagnosis of spontaneous canine hyperadrenocorticism: 2012 ACVIM consensus statement (small animal). J Vet Intern Med 2013, 27, 1292-1304.   DOI
8 Bhandal J, Langohr IM, Degner DA, Xie Y, Stanley BJ, Walshaw R. Histomorphometric analysis and regional variations of full thickness skin grafts in dogs. Vet Surg 2012, 41, 448-454.   DOI
9 Bhavani MS, Thirunavukkarasu P, Kavitha S, Nagarajan B, Baranidaran GR, Ali Bhat A. Steroid induced hyperadrenocorticism in dogs: a short study. J Anim Res 2015, 5, 203-207.   DOI
10 Black MM, Shuster S, Bottoms E. Skin collagen and thickness in Cushing's syndrome. Arch Dermatol Forsch 1973, 246, 365-368.   DOI
11 Blois SL, Caron I, Mitchell C. Diagnosis and outcome of a dog with iatrogenic hyperadrenocorticism and secondary pulmonary mineralization. Can Vet J 2009, 50, 397-400.
12 Braddock JA, Church DB, Robertson ID, Watson AD. Trilostane treatment in dogs with pituitary-dependent hyperadrenocorticism. Aust Vet J 2003, 81, 600-607.   DOI
13 Waller JM, Maibach HI. Age and skin structure and function, a quantitative approach (I): blood flow, pH, thickness, and ultrasound echogenicity. Skin Res Technol 2005, 11, 221-235.   DOI
14 Seidenari S, Pagnoni A, Di Nardo A, Giannetti A. Echographic evaluation with image analysis of normal skin: variations according to age and sex. Skin Pharmacol 1994, 7, 201-209.   DOI
15 Tan CY, Marks R, Payne P. Comparison of xeroradiographic and ultrasound detection of corticosteroid induced dermal thinning. J Invest Dermatol 1981, 76, 126-128.   DOI
16 Tan CY, Statham B, Marks R, Payne PA. Skin thickness measurement by pulsed ultrasound: its reproducibility, validation and variability. Br J Dermatol 1982, 106, 657-667.
17 Werth VP, Kligman AM, Shi X, Pagnoni A. Lack of correlation of skin thickness with bone density in patients receiving chronic glucocorticoid. Arch Dermatol Res 1998, 290, 388-393.   DOI
18 Young LA, Dodge JC, Guest KJ, Cline JL, Kerr WW. Age, breed, sex and period effects on skin biophysical parameters for dogs fed canned dog food. J Nutr 2002, 132 (6 Suppl 2), 1695S-1697S.   DOI
19 Burger IH. Energy needs of companion animals: matching food intakes to requirements throughout the life cycle. J Nutr 1994, 124 (12 Suppl), 2584S-2593S.   DOI
20 Zheng PS, Lavker RM, Lehmann P, Kligman AM. Morphologic investigations on the rebound phenomenon after corticosteroid-induced atrophy in human skin. J Invest Dermatol 1984, 82, 345-352.   DOI
21 Diana A, Guglielmini C, Fracassi F, Pietra M, Balletti E, Cipone M. Use of high-frequency ultrasonography for evaluation of skin thickness in relation to hydration status and fluid distribution at various cutaneous sites in dogs. Am J Vet Res 2008, 69, 1148-1152.   DOI
22 Cammarota T, Pinto F, Magliaro A, Sarno A. Current uses of diagnostic high-frequency US in dermatology. Eur J Radiol 1998, 27 (Suppl 2), S215-223.   DOI
23 Capewell S, Reynolds S, Shuttleworth D, Edwards C, Finlay AY. Purpura and dermal thinning associated with high dose inhaled corticosteroids. BMJ 1990, 300, 1548-1551.   DOI
24 Choi J, Kim H, Yoon J. Ultrasonographic adrenal gland measurements in clinically normal small breed dogs and comparison with pituitary-dependent hyperadrenocorticism. J Vet Med Sci 2011, 73, 985-989.   DOI
25 Diana A, Preziosi R, Guglielmini C, Degliesposti P, Pietra M, Cipone M. High-frequency ultrasonography of the skin of clinically normal dogs. Am J Vet Res 2004, 65, 1625-1630.   DOI
26 Eisenbeiss C, Welzel J, Schmeller W. The influence of female sex hormones on skin thickness: evaluation using 20 MHz sonography. Br J Dermatol 1998, 139, 462-467.   DOI
27 Fornage BD, McGavran MH, Duvic M, Waldron CA. Imaging of the skin with 20-MHz US. Radiology 1993, 189, 69-76.   DOI
28 Gniadecka M, Jemec GB. Quantitative evaluation of chronological ageing and photoageing in vivo: studies on skin echogenicity and thickness. Br J Dermatol 1998, 139, 815-821.   DOI
29 Huang HP, Yang HL, Liang SL, Lien YH, Chen KY. Iatrogenic hyperadrenocorticism in 28 dogs. J Am Anim Hosp Assoc 1999, 35, 200-207.   DOI
30 Kimura T, Doi K. Dorsal skin reactions of hairless dogs to topical treatment with corticosteroids. Toxicol Pathol 1999, 27, 528-535.   DOI
31 Kolbe L, Kligman AM, Schreiner V, Stoudemayer T. Corticosteroid-induced atrophy and barrier impairment measured by non-invasive methods in human skin. Skin Res Technol 2001, 7, 73-77.   DOI
32 Lee JY, Maibach HI. Corticosteroid skin atrophogenicity: assessment methods. Skin Res Technol 1998, 4, 161-166.   DOI
33 Miller WH, Griffin CE, Campbell KL, Muller GH. Muller & Kirk's Small Animal Dermatology. 7th ed. pp. 1-70, Saunders, Philadelphia, 2013.
34 Neiger R, Ramsey I, O'Connor J, Hurley KJ, Mooney CT. Trilostane treatment of 78 dogs with pituitary-dependent hyperadrenocorticism. Vet Rec 2002, 150, 799-804.   DOI
35 Peterson ME. Diagnosis of hyperadrenocorticism in dogs. Clin Tech Small Anim Pract 2007, 22, 2-11.   DOI
36 Reme CA, Dufour P. Effects of repeated topical application of a 0.0584% hydrocortisone aceponate spray on skin thickness in beagle dogs. Int J Appl Res Vet Med 2010, 8, 1-6.
37 Ruckstuhl NS, Nett CS, Reusch CE. Results of clinical examinations, laboratory tests, and ultrasonography in dogs with pituitary-dependent hyperadrenocorticism treated with trilostane. Am J Vet Res 2002, 63, 506-512.   DOI
38 Richard S, Duteil L, Poli F, de Rigal J, Querleux B, Queille-Roussel C, Leveque JL, Revuz J. Echographic assessment of corticosteroid-induced skin-thinning, including echogenicity measurement. Skin Res Technol 1996, 2, 18-22.   DOI
39 Rojko JL, Hoover EA, Martin SL. Histologic interpretation of cutaneous biopsies from dogs with dermatologic disorders. Vet Pathol 1978, 15, 579-589.